TY - JOUR
T1 - Translation
T2 - Expert Consensus on the Application of Artificial Liver Blood Purification System in the Treatment of Severe and Critical COVID-19
AU - National Clinical Research Center for Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
AU - Chen, Liang
AU - Chen, Yongping
AU - Chen, Yuemei
AU - Cheng, Mingliang
AU - Ding, Xiangchun
AU - Dou, Xiaoguang
AU - Du, Weibo
AU - Gan, Jianhe
AU - Gao, Hainv
AU - Gao, Zhiliang
AU - Geng, Jiawei
AU - Gong, Guozhong
AU - Guan, Yujuan
AU - Hu, Peng
AU - Hu, Yaoren
AU - Huang, Jianrong
AU - Jiang, Jianning
AU - Jiang, Ying’an
AU - Li, Jun
AU - Li, Jiabin
AU - Li, Jianguo
AU - Li, Lanjuan
AU - Li, Yongguo
AU - Lin, Feng
AU - Liu, Shourong
AU - Liu, Yingxia
AU - Lu, Qinghua
AU - Ma, Zhen
AU - Mao, Xiaorong
AU - Meng, Qinghua
AU - Peng, Liang
AU - Rao, Huiying
AU - Ren, Hong
AU - Shang, Jia
AU - Sheng, Guoping
AU - Sheng, Jifang
AU - Song, Hongli
AU - Su, Zhijun
AU - Tang, Lingling
AU - Tang, Hong
AU - Wang, Guiqiang
AU - Wang, Kai
AU - Wu, Xiaoping
AU - Xie, Qing
AU - Xu, Kaijin
AU - Xu, Xiaowei
AU - Yang, Dongliang
AU - Ye, Juzhen
AU - Yu, Liang
AU - Zhao, Yingren
N1 - Publisher Copyright:
Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease. The artificial liver blood purification system can remove inflammatory factors, alleviate the damage of the inflammatory response to the body, and has important value for the treatment of severe COVID-19. Led by Academician Lanjuan Li, based on the experience of treating patients across the country, integrating the opinions of experts from all over the country, the center summarized and formulated the consensus including the basic principles, treatment indications, relative contraindications, mode selection, monitoring indicators, and efficacy evaluation of artificial liver, which provides reference for treatment of severe COVID-19 patients.
AB - The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease. The artificial liver blood purification system can remove inflammatory factors, alleviate the damage of the inflammatory response to the body, and has important value for the treatment of severe COVID-19. Led by Academician Lanjuan Li, based on the experience of treating patients across the country, integrating the opinions of experts from all over the country, the center summarized and formulated the consensus including the basic principles, treatment indications, relative contraindications, mode selection, monitoring indicators, and efficacy evaluation of artificial liver, which provides reference for treatment of severe COVID-19 patients.
KW - COVID-19
KW - artificial
KW - coronavirus infections
KW - expert consensus
KW - liver
UR - https://www.scopus.com/pages/publications/85102570759
U2 - 10.1097/IM9.0000000000000021
DO - 10.1097/IM9.0000000000000021
M3 - 文章
AN - SCOPUS:85102570759
SN - 2096-7241
VL - 2
SP - 64
EP - 66
JO - Infectious Microbes and Diseases
JF - Infectious Microbes and Diseases
IS - 2
ER -
可持续发展目标 3 良好健康与福祉